Repligen Corp. (RGEN)
176.93
-1.78
(-1.00%)
USD |
NASDAQ |
Oct 23, 16:00
176.66
-0.27
(-0.15%)
After-Hours: 20:00
Repligen Enterprise Value : 9.864B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 9.864B |
| October 22, 2026 | 9.965B |
| October 21, 2026 | 10.04B |
| October 20, 2026 | 9.974B |
| October 19, 2026 | 9.836B |
| October 16, 2026 | 9.779B |
| October 15, 2026 | 10.27B |
| October 14, 2026 | 9.936B |
| October 13, 2026 | 9.779B |
| October 12, 2026 | 9.615B |
| October 09, 2026 | 9.692B |
| October 08, 2026 | 9.126B |
| October 07, 2026 | 9.316B |
| October 06, 2026 | 9.747B |
| October 05, 2026 | 10.57B |
| October 02, 2026 | 10.13B |
| October 01, 2026 | 9.881B |
| September 30, 2026 | 10.73B |
| September 29, 2026 | 10.86B |
| September 28, 2026 | 10.83B |
| September 25, 2026 | 10.58B |
| September 24, 2026 | 10.64B |
| September 23, 2026 | 10.29B |
| September 22, 2026 | 10.42B |
| September 21, 2026 | 10.08B |
| Date | Value |
|---|---|
| September 18, 2026 | 9.862B |
| September 17, 2026 | 9.935B |
| September 16, 2026 | 9.637B |
| September 15, 2026 | 9.740B |
| September 14, 2026 | 9.360B |
| September 11, 2026 | 9.201B |
| September 10, 2026 | 9.173B |
| September 09, 2026 | 9.194B |
| September 08, 2026 | 9.390B |
| September 04, 2026 | 9.338B |
| September 03, 2026 | 9.451B |
| September 02, 2026 | 9.639B |
| September 01, 2026 | 9.474B |
| August 31, 2026 | 10.09B |
| August 28, 2026 | 9.827B |
| August 27, 2026 | 10.15B |
| August 26, 2026 | 10.05B |
| August 25, 2026 | 10.13B |
| August 24, 2026 | 10.13B |
| August 21, 2026 | 10.10B |
| August 20, 2026 | 10.05B |
| August 19, 2026 | 9.832B |
| August 18, 2026 | 9.256B |
| August 17, 2026 | 9.419B |
| August 14, 2026 | 9.294B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Anika Therapeutics, Inc. | 273.50M |
| Precigen, Inc. | 2.276B |
| Liquidia Corp. | 3.699B |
| Harmony Biosciences Holdings, Inc. | 1.653B |
| Agilent Technologies, Inc. | 50.99B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.008M |
| Revenue (Quarterly) | 204.13M |
| Total Expenses (Quarterly) | 199.12M |
| EPS Diluted (Quarterly) | 0.0884 |
| Gross Profit Margin (Quarterly) | 49.25% |
| Profit Margin (Quarterly) | 2.45% |
| Earnings Yield | 0.41% |
| Operating Earnings Yield | 0.71% |
| Normalized Earnings Yield | 0.4613 |